Evidence map›Paper›PMID 19433779›Full record

ArticleHypertension (Dallas, Tex. : 1979)2009

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

Alissa R Caton, Erin M Bell, Charlotte M Druschel, Martha M Werler, Angela E Lin, Marilyn L Browne, Louise-Anne McNutt, Paul A Romitti, Allen A Mitchell, Richard S Olney and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 8 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 8 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Alissa R CatonDepartment of Epidemiology and Biostatistics, University at Albany, Rensselaer, NY, USA. arc05@health.state.ny.us
Erin M Bell
Charlotte M Druschel
Martha M Werler
Angela E Lin
Marilyn L Browne
Louise-Anne McNutt
Paul A Romitti
Allen A Mitchell
Richard S Olney
Adolfo Correa
National Birth Defects Prevention Study
Boston University · USMassachusetts General Hospital · USNew York State Department of Health · USUniversity of Iowa · US

Funding

New York Center for Birth Defects Research and PreventionU01DD000487 · DD · NYSDOH/HEALTH RESEARCH, INC. · PI BROWNE, MARILYN L. · 2009 to 2013
$3.8M
NCBDD CDC HHS U01 DD000487PHS HHS U50CCU213244
6 · The paper itself

Abstract

We used data from the National Birth Defects Prevention Study, a population-based, case-control study, to examine whether previously reported associations between antihypertensive medications and cardiovascular malformations could be confirmed and to explore whether new associations might be identified. Cases (n=5021) were ascertained through birth defects surveillance systems from 1997 through 2003 in 10 US states. Controls (n=4796) were live births without birth defects selected randomly from birth certificates or hospital discharge listings in the same geographic regions. Logistic regression was used to examine the relationship between antihypertensive medication treatment and the occurrence of cardiovascular malformations while controlling for confounding variables. First-trimester treatment with antihypertensive medication was associated with pulmonary valve stenosis (odds ratio [OR]: 2.6; 95% CI: 1.3 to 5.4), Ebstein malformation (crude OR: 11.4; exact 95% CI: 2.8 to 34.1), coarctation of the aorta (OR: 3.0; 95% CI: 1.3 to 6.6), and secundum atrial septal defects (OR: 2.4; 95% CI: 1.3 to 4.4). Treatment initiated after the first trimester was associated with pulmonary valve stenosis (OR: 2.4; 95% CI: 1.1 to 5.4), perimembranous ventricular septal defects (OR: 2.3; 95% CI: 1.2 to 4.6), and secundum atrial septal defects (OR: 2.4; 95% CI: 1.3 to 4.4). Untreated hypertension was associated with Ebstein malformation (OR: 2.1; 95% CI: 1.0 to 4.3) and secundum atrial septal defects (OR: 1.3; 95% CI: 1.0 to 1.6). Antihypertensive medication use and/or the underlying hypertension might increase the risk of having an infant with specific left and right obstructive and septal defects. Additional studies with adequate power will be needed to confirm these findings.

Indexed as

Abnormalities, Drug-InducedAdultAntihypertensive AgentsCardiovascular AbnormalitiesCase-Control StudiesFemaleHumansHypertensionInfant, NewbornLogistic ModelsMaleMaternal AgeOdds RatioPregnancyPregnancy Complications, CardiovascularPregnancy Trimester, FirstAntihypertensive Agents

Identifiers

PMID19433779
PMCPMC4913772
OpenAlexW2037121186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.